Quantitative structure and bioactivity relationship study on HCV NS5B polymerase inhibitors

SAR and QSAR in Environmental Research

Volumn 25, Issue 1, 2014, Pages 1-15

  Wang, M ^a   Zhong, M ^a   Yan, A ^a   Li, L ^a   Yu, C ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

HCV NS5B polymerase inhibitors; Kohonen's self organizing map (SOM); multilinear regression (MLR); quantitative structure activity relationships (QSAR); support vector machine (SVM)

Indexed keywords

CORRELATION METHODS; HYDROGEN BONDS; SELF ORGANIZING MAPS; STATISTICAL TESTS; SUPPORT VECTOR MACHINES; VIRUSES;

HEPATITIS C VIRUS NS5B POLYMERASE; HEPATITIS C VIRUS NS5B POLYMERASE INHIBITOR; KOHONEN SELF-ORGANIZING MAP; KOHONEN SELF-ORGANIZING MAPS; MULTILINEAR REGRESSION; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT VECTOR MACHINE; SUPPORT VECTORS MACHINE;

MOLECULES;

HEPATITIS C VIRUS;

ENZYME INHIBITOR; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; HEPATITIS C VIRUS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL;

BINDING SITES; ENZYME INHIBITORS; HEPACIVIRUS; LINEAR MODELS; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84896702008     PISSN: 1062936X     EISSN: 1029046X     Source Type: Journal    
DOI: 10.1080/1062936X.2013.820790     Document Type: Article

References (36)

1. F. Ruebsam, C.V. Tran, L.S. Li, S.H. Kim, A.X. Xiang, Y. Zhou, J.K. Blazel, Z. Sun, P.S. Dragovich, J. Zhao, H.M. McGuire, D.E. Murphy, M.T. Tran, N. Stankovic, D.A. Ellis, A. Gobbi, R.E. Showalter, S.E. Webber, A.M. Shah, M. Tsan, R.A. Patel, L.A. Lebrun, H.J. Hou, R. Kamran, M.V. Sergeeva, D.M. Bartkowski, T.G. Nolan, D.A. Norris and L. Kirkovsky, 5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase, Bioorg. Med. Chem. Lett. 19, (2009), 451-458.
2. I. Stansfield, S. Avolio, S. Colarusso, N. Gennari, F. Narjes, B. Pacini, S. Ponzi and S. Harper, Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acid, Bioorg. Med. Chem. Lett. 14, (2004), 5085-5088.
3. K.X. Chen, C.A. Lesburg, B. Vibulbhan and W. Yang, A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitors, J. Med. Chem. 55, (2012), 2089-2101.
4. A.C. Krueger, D.L. Madigan, W.W. Jiang, W.M. Kati, D. Liu, Y. Liu, C.J. Maring, S. Masse, K.F. McDaniel, T. Middleton, H. Mo, A. Molla, D. Montgomery, J.K. Pratt, T.W. Rockway, R. Zhang and D.J. Kempf, Inhibitors of HCV NS5B polymerase: Synthesis and structure-activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides, Bioorg. Med. Chem. Lett. 16, (2006), 3367-3370.
5. T. Ishida, T. Suzuki, S. Hirashima, K. Mizutani, A. Yoshida, I. Ando, S. Ikeda, T. Adachi and H. Hashimoto, Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: Identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole, Bioorg. Med. Chem. Lett. 16, (2006), 1859-1863.
6. D. Das, J. Hong, S.H. Chen, G. Wang, L. Beigelman, S.D. Seiwert and B.O. Buckman, Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors, Bioorg. Med. Chem. 19, (2011), 4690-4703.
7. M.H. Powdrill, J.A. Bernatchez and M. Gotte, Inhibitors of the hepatitis C virus RNA-dependent RNA polymerase NS5B, Viruses 2, (2010), 2169-2195.
8. M. Wang, K. Wang, A. Yan and C. Yu, Classification of HCV NS5B polymerase inhibitors using support vector machine, Int. J. Mol. Sci. 13, (2012), 4033-4047.
9. C. Hansch and T. Fujita, Status of QSAR at the End of the Twentieth Century, in Classical and Three-Dimensional QSAR in Agrochemistry, Vol. 606, American Chemical Society, 1995, pp. 1-12.
10. A. Yan, Y. Chong, L. Wang, X. Hu and K. Wang, Prediction of biological activity of Aurora-A kinase inhibitors by multilinear regression analysis and support vector machine, Bioorg. Med. Chem. Lett. 21, (2011), 2238-2243.
11. P.V. Khadikar, V. Sharma, S. Karmarkar and C.T. Supuran, QSAR studies on benzene sulfonamide carbonic anhydrase inhibitors: Need of hydrophobic parameter for topological modeling of binding constants of sulfonamides to human CA-II, Bioorg. Med. Chem. Lett. 15, (2005), 923-930.
12. K.X. Chen, H.Y. Xie and Z.G. Li, 2D-QSAR studies on anthranilic acid derivatives: A novel class of allosteric inhibitors of hepatitis C NS5B polymerase, Chinese J. Struct. Chem. 28, (2009), 1217-1225.
13. P.D. Patel, M.R. Patel, N. Kaushik-Basu and T.T. Talele, 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors, J. Chem. Inf. Model. 48, (2008), 42-55.
14. I. Musmuca, A. Caroli, A. Mai, N. Kaushik-Basu, P. Arora and R. Ragno, Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors, J. Chem. Inf. Model. 50, (2010), 662-676.
15. E. Pourbasheer, S. Riahi, M.R. Ganjali and P. Norouzi, QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine, Mol. Divers. 15, (2011), 645-653.
16. ADRIANA.Code 2.2, Molecular Networks GmbH, Erlangen, Germany, 2012; software available at http://www.molecular-networks.com, Vol. ADRIANA.Code, Molecular Networks GmbH, Erlangen, Germany. http://www.molecular-networks.com (accessed Dec 2012).
17. T. Kohonen, Self-organized formation of topologically correct feature maps, Biol. Cybernet. 43, (1982), 59-69.
18. C. Cortes and V. Vapnik, Support-vector networks, Mach. Learn. 20, (1995), 273-297.
19. R. Tedesco, A.N. Shaw, R. Bambal, D. Chai, N.O. Concha, M.G. Darcy, D. Dhanak, D.M. Fitch, A. Gates, W.G. Gerhardt, D.L. Halegoua, C. Han, G.A. Hofmann, V.K. Johnston, A.C. Kaura, N. Liu, R.M. Keenan, J. Lin-Goerke, R.T. Sarisky, K.J. Wiggall, M.N. Zimmerman, and K.J. Duffy, 3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase, J. Med. Chem. 49 (2006), pp. 971-983.
20. G. Burton, T.W. Ku, T.J. Carr, T. Kiesow, R.T. Sarisky, J. Lin-Goerke, A. Baker, D.L. Earnshaw, G.A. Hofmann, R.M. Keenan and D. Dhanak, Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture, Bioorg. Med. Chem. Lett. 15, (2005), 1553-1556.
21. J. de Vicente, R.T. Hendricks, D.B. Smith, J.B. Fell, J. Fischer, S.R. Spencer, P.J. Stengel, P. Mohr, J.E. Robinson, J.F. Blake, R.K. Hilgenkamp, C. Yee, G. Adjabeng, T.R. Elworthy, J. Tracy, E. Chin, J. Li, B. Wang, J.T. Bamberg, R. Stephenson, C. Oshiro, S.F. Harris, M. Ghate, V. Leveque, I. Najera, S. Le Pogam, S. Rajyaguru, G. Ao-Ieong, L. Alexandrova, S. Larrabee, M. Brandl, A. Briggs, S. Sukhtankar, R. Farrell and B. Xu, Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinediones, Bioorg. Med. Chem. Lett. 19, (2009), 3642-3646.
22. R. Tedesco, D. Chai, M.G. Darcy, D. Dhanak, D.M. Fitch, A. Gates, V.K. Johnston, R.M. Keenan, J. Lin-Goerke, R.T. Sarisky, A.N. Shaw, K.L. Valko, K.J. Wiggall, M.N. Zimmerman and K.J. Duffy, Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzothiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitors, Bioorg. Med. Chem. Lett. 19, (2009), 4354-4358.
23. F. Ruebsam, S.E. Webber, M.T. Tran, C.V. Tran, D.E. Murphy, J. Zhao, P.S. Dragovich, S.H. Kim, L.S. Li, Y. Zhou, Q. Han, C.R. Kissinger, R.E. Showalter, M. Lardy, A.M. Shah, M. Tsan, R. Patel, L.A. Lebrun, R. Kamran, M.V. Sergeeva, D.M. Bartkowski, T.G. Nolan, D.A. Norris and L. Kirkovsky, Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase, Bioorg. Med. Chem. Lett. 18, (2008), 3616-3621.
24. J.P. Powers, D.E. Piper, Y. Li, V. Mayorga, J. Anzola, J.M. Chen, J.C. Jaen, G. Lee, J. Liu, M.G. Peterson, G.R. Tonn, Q. Ye, N.P. Walker and Z. Wang, SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase, J. Med. Chem. 49, (2006), 1034-1046.
25. L.S. Li, Y. Zhou, D.E. Murphy, N. Stankovic, J. Zhao, P.S. Dragovich, T. Bertolini, Z. Sun, B. Ayida, C.V. Tran, F. Ruebsam, S.E. Webber, A.M. Shah, M. Tsan, R.E. Showalter, R. Patel, L.A. Lebrun, D.M. Bartkowski, T.G. Nolan, D.A. Norris, R. Kamran, J. Brooks, M.V. Sergeeva, L. Kirkovsky, Q. Zhao and C.R. Kissinger, Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)- 5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments, Bioorg. Med. Chem. Lett. 18, (2008), 3446-3455.
26. A. Gopalsamy, R. Chopra, K. Lim, G. Ciszewski, M. Shi, K.J. Curran, S.F. Sukits, K. Svenson, J. Bard, J.W. Ellingboe, A. Agarwal, G. Krishnamurthy, A.Y. Howe, M. Orlowski, B. Feld, J. O'Connell and T.S. Mansour, Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site, J. Med. Chem. 49, (2006), 3052-3055.
27. P.S. Dragovich, J.K. Blazel, D.A. Ellis, Q. Han, R. Kamran, C.R. Kissinger, L.A. LeBrun, L.S. Li, D.E. Murphy, M. Noble, R.A. Patel, F. Ruebsam, M.V. Sergeeva, A.M. Shah, R.E. Showalter, C.V. Tran, M. Tsan, S.E. Webber, L. Kirkovsky and Y. Zhou, Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)- 5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents, Bioorg. Med. Chem. Lett. 18, (2008), 5635-5639.
28. J. de Vicente, R.T. Hendricks, D.B. Smith, J.B. Fell, J. Fischer, S.R. Spencer, P.J. Stengel, P. Mohr, J.E. Robinson, J.F. Blake, R.K. Hilgenkamp, C. Yee, J. Zhao, T.R. Elworthy, J. Tracy, E. Chin, J. Li, A. Lui, B. Wang, C. Oshiro, S.F. Harris, M. Ghate, V.J. Leveque, I. Najera, S. Le Pogam, S. Rajyaguru, G. Ao-Ieong, L. Alexandrova, B. Fitch, M. Brandl, M. Masjedizadeh, S.Y. Wu, S. de Keczer and T. Voronin, Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: Synthesis and optimization studies of benzothiazine-substituted tetramic acids, Bioorg. Med. Chem. Lett. 19, (2009), 5648-5651.
29. F.E. Grubbs, Sample criteria for testing outlying observations, Ann. Math. Statist. 21, (1950), 27-58.
30. MOE (The Molecular Operating Environment) 2010. Chemical Computing Group Inc, Japan, 2010; software available at http://www.chemcomp.com/, Vol. MOE (The Molecular Operating Environment), Version.2010; software available from Chemical Computing Group Inc.
31. Sonnia 4.0. Molecular Networks GmbH, Erlangen, Germany, 2012; software available at http://www.molecular-networks.com/, Vol. SONNIA can be obtained from Molecular Networks GmbH, Erlangen, Germany.
32. J. Sadowski and J. Gasteiger, From atoms and bonds to three-dimensional atomic coordinates: Automatic model builders, J. Chem. Rev. 93, (1993), 2567-2581.
33. D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward and K.D. Kopple, Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem. 45, (2002), 2615-2623.
34. J.L. Rodgers and W.A. Nicewander, Thirteen ways to look at the correlation coefficient, Am. Stat. 42, (1988), 59-66.
35. C.C. Chang and C.J. Lin, Libsvm; Software available at http://www.csie.ntu.edu.tw/~cjlin/libsvm, Vol. C.C. Chang, C.J. Lin, LIBSVM: A library for support vector machine. Software available at http://www.csie.ntu.edu.tw/~cjlin/libsvm, 2001.
36. C.A. Boneau, The effects of violations of assumptions underlying the t test, Psychol. Bull. 57, (1960), 49-64.